Skip to main content
MBOT logo

MBOT · Microbot Medical Inc. · Analyst Estimates

Track MBOT — free
$1.12 +0.05 (+4.67%) At close · Oct 7
Market Cap
$75.22M
Shares
67.16M
Volume · Oct 7 649.76K Avg daily vol (3M) 649.36K

Analyst Estimates

Compare analyst forecasts for Microbot Medical Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-05 19:50 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.31
-0.3
-0.29
—
-0.31333
-0.28
-0.3
-0.3
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
1
0
1
1
Revenue
USD
Publication date not stated
996000
1398670
1900000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
3
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.37
-0.30333
-0.26
—
-0.34333
-0.29667
-0.28667
-0.32
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
1
1
1
0
Revenue
USD
Publication date not stated
6500000
8050000
9600000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
2
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.08
-0.08
-0.08
—
-0.08333
-0.07333
-0.08
-0.08
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
1
0
0
1
Revenue
USD
Publication date not stated
250000
416670
600000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
3
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.09
-0.08333
-0.08
—
-0.09333
-0.07667
-0.08333
-0.08333
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
1
0
1
1
Revenue
USD
Publication date not stated
400000
666670
1000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
3
— — — — — — — —
Key facts CIK 883975 CUSIP 59503A204 13F (30d) 2 filings 2 filers Visit website Investor relations